pentobarbital has been researched along with Focal Neurologic Deficits in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilmore, DP | 1 |
| Shaikh, AA | 1 |
| Popova, VN | 1 |
| Tsyganova, AM | 1 |
2 other studies available for pentobarbital and Focal Neurologic Deficits
| Article | Year |
|---|---|
The effect of prostaglandin E2 in inducing sedation in the rat.
Topics: Animals; Aspirin; Bemegride; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Drug Syn | 1972 |
[Neurologic manifestations of acute intermittent porphyria provoked by the use of barbiturates and estrogens (clinico-biochemical findings)].
Topics: Acute Disease; Adult; Female; Humans; Menstruation; Neurologic Manifestations; Pentobarbital; Porphy | 1971 |